T cells, α-synuclein and Parkinson disease
Authors:
- 13 January 2022
- book chapter
- Published by Elsevier
- Vol. 184, 439-455
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (01NS095435)
- National Institutes of Health
- JPB Foundation
This publication has 218 references indexed in Scilit:
- Alpha-Synuclein Induces Lysosomal Rupture and Cathepsin Dependent Reactive Oxygen Species Following EndocytosisPLOS ONE, 2013
- α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?Acta Neuropathologica, 2013
- CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s DiseaseJournal of Neuroimmune Pharmacology, 2012
- Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsyJournal of Neural Transmission, 2011
- Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypesImmunogenetics, 2011
- Astrocytes and Therapeutics for Parkinson's DiseaseNeurotherapeutics, 2010
- Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s DiseaseNeurotoxicity Research, 2009
- Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunctionActa Neuropathologica, 2009
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003